Duquesne
TEVA · Medicine & biotech

Teva

Makes low-cost copies of popular medicines, plus its own drugs.
Sold some
Duquesne still owns 624,999 shares of Teva, worth about $21 million, or less than $1 of every $100 they have in stocks. Between April and June they sold 1.8 million shares (down 74%).
Mar 31
2,377,285
Jun 30
624,999

The numbers

Shares they own
624,999
Change since Mar 31
−1,752,286
−73.7%
Shares on Mar 31
2,377,285
Value on Jun 30, 2026
$21,175,000
about $21 million
Share of their money
0.5%
less than $1 of every $100 · 45th of 85
Price per share on Jun 30
$33.88
Value of the shares they sold
about $59 million
at the Jun 30 price
Kind
Shares
More about Teva
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works